CiVi Biopharma Holdings, Inc. — Form D
CiVi Biopharma Holdings, Inc. of Chevy Chase, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-22. The offering totals $49.0M, of which $49.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-05-22
- Form: D
- Accession: 0001740380-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $49.0M
- Amount sold: $49.0M
- Investors: 6
- Date of first sale: 2018-05-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-312966
Issuer
- Name: CiVi Biopharma Holdings, Inc.
- CIK: 0001740380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5425 Wisconsin Ave., Chevy Chase, MD, 20815
- Phone: 301.968.2392
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Henrik Oerum | Executive Officer | Chevy Chase, MD |
| Aaron Davis | Director | Miami, FL |
| Matthew Pietras | Executive Officer | Huntersville, NC |
| Shalom Jacobovitz | Director | Salt Lake City, UT |
| Shalom Jacobovitz | Executive Officer | Salt Lake City, UT |
| Carole Nuechterlein | Director | Chevy Chase, MD |
| Christopher Fuglesang | Director | Chevy Chase, MD |
| Henrik Oerum | Director | Chevy Chase, MD |
Other filings by this issuer (1)
More